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Abstract
Background: Maternal nutrition during pregnancy and infant nutrition in the early postnatal period (lactation) are
critically involved in the development and health of the newborn infant. The Maternal Nutrition and Offspring’s
Epigenome (MANOE) study was set up to assess the effect of maternal methyl-group donor intake (choline, betaine,
folate, methionine) on infant DNA methylation. Maternal intake of dietary methyl-group donors was assessed using
a food-frequency questionnaire (FFQ). Before and during pregnancy, we evaluated maternal methyl-group donor
intake through diet and supplementation (folic acid) in relation to gene-specific (IGF2 DMR, DNMT1, LEP, RXRA)
buccal epithelial cell DNA methylation in 6 months old infants (n = 114) via pyrosequencing. In the early postnatal
period, we determined the effect of maternal choline intake during lactation (in mothers who breast-fed for at least
3 months) on gene-specific buccal DNA methylation (n = 65).
Results: Maternal dietary and supplemental intake of methyl-group donors (folate, betaine, folic acid), only in the
periconception period, was associated with buccal cell DNA methylation in genes related to growth (IGF2 DMR),
metabolism (RXRA), and appetite control (LEP). A negative association was found between maternal folate and folic
acid intake before pregnancy and infant LEP (slope = −1.233, 95% CI −2.342; −0.125, p = 0.0298) and IGF2 DMR
methylation (slope = −0.706, 95% CI −1.242; −0.107, p = 0.0101), respectively. Positive associations were observed for
maternal betaine (slope = 0.875, 95% CI 0.118; 1.633, p = 0.0241) and folate (slope = 0.685, 95% CI 0.245; 1.125, p = 0.
0027) intake before pregnancy and RXRA methylation. Buccal DNMT1 methylation in the infant was negatively
associated with maternal methyl-group donor intake in the first and second trimester of pregnancy and negatively
in the third trimester. We found no clear association between maternal choline intake during lactation and buccal
infant DNA methylation.
Conclusions: This study suggests that maternal dietary and supplemental intake of methyl-group donors, especially
in the periconception period, can influence infant’s buccal DNA methylation in genes related to metabolism,
growth, appetite regulation, and maintenance of DNA methylation reactions.
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Background
During pregnancy, environmental exposures can influ-
ence the development of the offspring and increase the
risk for metabolic diseases, like obesity, later in life. One
maternal factor that has consistently been shown to
influence later phenotype is maternal nutrition [1]. This
has been most clearly shown in studies of the Dutch
Hunger Winter (1944–1945), a 5-month period of
extreme food shortage in the Netherlands at the end of
World War II. Long-term follow-up studies from this
cohort found that exposure to famine in early gestation
was associated with low birth weight and increased risk
of obesity in adulthood, whereas, exposure in late gesta-
tion showed decreased glucose tolerance [2]. Studies
from this cohort indicate that there are different windows
of susceptibility during pregnancy (embryogenesis, or-
ganogenesis, and tissue differentiation) where maternal
nutrition can influence offspring’s health [3]. In addition,
the early postnatal period is another critical period in
which nutrition can program the infant. Several physio-
logical and metabolic mechanisms are not fully mature at
birth and continue to develop in the immediate postnatal
period [4].
One of the underlying mechanisms responsible for
metabolic programming is epigenetic modifications,
such as DNA methylation [5]. The process of methyla-
tion and demethylation is a natural process allowing the
cell to grow and differentiate. Shortly after fertilization,
DNA methylation marks on the maternal and paternal
genome are globally demethylated, which is followed by
de novo methylation just before implantation. This is a
critical window of fetal development during pregnancy
where dietary factors can influence the fetal methylome
[6]. Methyl-group donors derived from food (choline,
betaine, folate, and methionine) and supplements (folic
acid), which contains a methyl-group (CH3), enter the
one-carbon (I-C) metabolism at different sites and are,
in the end, converted to the universal methyl-group
donor S-adenosylmethionine (SAM). SAM will donate a
methyl-group for the methylation of the DNA [7].
Choline plays a role in the structural integrity of cell
membranes, in the lipid-cholesterol transport and metab-
olism, and in normal brain development (precursor of
acetylcholine) [8, 9]. Betaine is essential in the preimplan-
tation embryo, in which it may play a role as an osmolyte,
and for correct neural tube formation [10]. The intake of
folate or vitamin B9 (400 μg per day) is recommended
during pregnancy to prevent neural tube defects, placental
abruption, preterm birth, and low birth weight [11, 12].
Methionine is an indispensable amino acid required for
protein synthesis. Diets with an inappropriate balance of
methionine can adversely affect fetal development [13].
Many animal studies examined the effect of maternal
methyl-group-supplemented diets on offspring epigenome,
health, and longevity. A classic example is the agouti viable
yellow mouse, which has a yellow coat color, is obese,
hyperinsulinemic, and is more susceptible to cancer. Mater-
nal dietary supplementation with methyl-group donors
shifts the coat color of the offspring towards the brown
pseudoagouti phenotype and lowers the disease risk [14].
Animal models have confirmed the biological possibil-
ity of fetal programming in response to maternal
methyl-group donor supplementation and make it rea-
sonable to think that similar processes could happen in
humans. Until now, some studies in humans have
shown that maternal methyl-group donor intake can
influence offspring methylation. For example, Increased
IGF2 methylation and decreased PEG3 and LINE-1
methylation were observed in cord blood with increased
folic acid supplement consumption after 12 weeks of preg-
nancy [15]. However, the long-term effects on offspring
health remain unknown in humans.
Methyl-groups are transferred from SAM to the DNA
by DNA methyltransferases (DNMTs). DNMT1 is re-
sponsible for maintaining DNA methylation patterns
through mitosis [16]. DNMT3A and DNMT3B are
responsible for the establishment of new or “de novo”
DNA methylation patterns during early embryogenesis,
which is a vulnerable period where nutritional insults
can disrupt the correct establishment of epigenetic
marks. According to Heijmans et al. [5], a decrease of
5.2% in insulin-like growth factor 2 (IGF2) differentially
methylated region (DMR) whole blood DNA methyla-
tion was observed in 60 adults exposed to periconcep-
tion famine compared to same-sex siblings who were
not exposed. This association was only seen when there
was an exposure in early gestation, not in mid or late
gestation. IGF2 is a maternally imprinted gene that is
important for fetal growth and development. The IGF2
DMR is only methylated on the maternal allele, so this
region might be vulnerable to nutritional exposures in
the pre- and periconception period [17]. Another study
from the Dutch Hunger Winter found a significant
increase in leptin (LEP) whole blood DNA methylation
of men exposed to famine in early and late gestation.
These results suggest that environmentally induced
DNA methylation changes may not be limited to the
periconception period (period starting 14 weeks before
conception until 10 weeks postconception) [18] but it
appears to extend to the whole prenatal period [19].
Leptin is a hormone, produced by adipose tissue, which
is implicated in appetite control (inhibits food intake)
and fat metabolism. LEP promoter methylation differ-
ences can influence LEP expression [20]. Godfrey et al.
[21] observed that lower maternal carbohydrate intake
in early pregnancy was associated with higher methyla-
tion of the retinoid X receptor-α (RXRA) gene in umbil-
ical cord blood. In addition, the authors found that
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greater methylation levels in RXRA were more strongly
correlated with greater adiposity (fat mass and percent-
age fat mass) in later childhood (9 years old) in two in-
dependent cohorts. RXRA is known to have beneficial
effects on insulin sensitivity, adipogenesis, and fat me-
tabolism, through its binding to the transcription factor
peroxisome proliferator-activated receptor (PPAR) [22].
Early postnatal life has shown to be another critical
window for metabolic programming in which nutrition
can induce epigenetic changes in the infant. In the early
postnatal period, newborns are either breast-fed or
formula-fed. The ideal nutrient composition of breast
milk and the peculiar feeding behavior associated with
breastfeeding seem to have a protective effect against
the development of obesity later in life. However, the
different epigenetic mechanisms involved remain unclear
[23]. One study found that the duration of breastfeeding
was negatively associated with LEP whole blood methy-
lation in 17 months old children. It was hypothesized
that the breast milk content contributes to programming
of the neuroendocrine system by changing LEP methyla-
tion. The decrease in LEP methylation could be one of
the mechanisms by which breastfeeding contributes to
protection against childhood obesity [20]. Some human
studies hypothesize that specific breast milk components
could possibly induce epigenetic changes and influence
the child’s health outcome. For example, the high chol-
esterol content of breast milk may reduce endogenous
cholesterol synthesis, probably by down-regulation of
hepatic hydroxymethyl glutaryl coenzyme A (HMGCoA)
reductase through epigenetic mechanisms [23]. Conse-
quently, it is important to investigate the effect of mater-
nal dietary choline intake during lactation on infant
DNA methylation levels. Hence, the methyl-group donor
choline can influence choline breast milk composition
and infant choline status. Folate breast milk concentra-
tion on the other hand is maintained even when the
mother is folate deficient and is unaffected by maternal
folic acid supplementation [24]. Methionine is present in
breast milk in low concentrations. Amino acid compos-
ition of breast milk can be influenced by lactation stage
but not by maternal dietary protein intake [25, 26].
In this study, we investigated the effect of maternal
dietary methyl-group donor intake (choline, betaine, fol-
ate, and methionine) and supplemental intake (folic acid)
before and during each trimester of pregnancy on gene-
specific methylation (DNMT1, IGF2 DMR, RXRA, and
LEP) in buccal epithelial cells of 6 months old infants.
Buccal swabs were chosen to collect DNA because the
samples are easy to collect and it is a non-invasive tech-
nique, which is important to consider when taken DNA
samples from infants. Buccal samples mainly exist of
exfoliated (dead) epithelial cells but have a more
homogenous cell population compared to blood samples
[27]. Next, we determined the effect of maternal choline
intake during lactation, in mothers who breast-fed for at
least 3 months, on gene-specific buccal DNA methyla-
tion. In the gene-specific DNA methylation analysis, we
included DNMT 1, IGF2 DMR, RXRA, and LEP.
Methods
Study subjects
We studied participants enrolled in the MANOE (Mater-
nal Nutrition and Offspring’s Epigenome) study, an on-
going prospective, observational cohort study initiated in
April 2012. Healthy Caucasian women who desired to
become pregnant or who were in the first trimester of
pregnancy were recruited at the Department of Obstetrics
and Gynecology of the University Hospitals Leuven
(Belgium). We enrolled 150 women (34 women before
pregnancy and 116 in the first trimester of pregnancy)
between April 2012 and January 2015. The last delivery of
the cohort took place in September 2015 and the last
6 months postpartum (PP) visit in March 2016. Exclusion
criteria were the following: non-Caucasian women, mul-
tiple pregnancies (twins, triplets, etc.), and infertility treat-
ment. Of the 150 enrolled women, 36 mother–infant pairs
were excluded from analysis due to missing nutritional
data (n = 2), missing buccal swab samples (n = 15), devel-
opment of pregnancy complications (gestational diabetes
(n = 8) and preeclampsia (n = 1)), preterm delivery (n = 6),
extreme high intake of folic acid (4 mg/day) (n = 2), and
birth defects (n = 2). This gives us a total of 114 mother–
infant pairs for statistical analysis. Further statistical ana-
lysis was performed on a subsample of 65 lactating
mother–infant pairs. A flowchart of the mother–infant
pairs enrolled in the MANOE study and included in the
statistical analysis is presented in Fig. 1. The recruitment
process has been described in more detail in a previous
study [28].
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all proce-
dures involving human subjects were approved by the
UZ Leuven-Committee for Medical Ethics (reference
number: ML7975). Written informed consent was ob-
tained from all subjects.
Maternal and neonatal measurements
All 114 women were followed up during pregnancy at
their scheduled ultrasounds (11–13 weeks, 18–22 weeks,
and 30–34 weeks of gestation), 6 weeks, and 6 months
PP. From the women recruited before pregnancy (n = 34),
extra measurements were taken before conception. To
assess maternal intake of dietary methyl-group donors
(methionine, folate, betaine, and choline) before preg-
nancy, during each trimester of pregnancy, and PP, a food-
frequency questionnaire (FFQ) was developed, validated
[29, 30], and implemented in the MANOE study. The
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FFQ contains 51 food items and women were asked to
indicate their answers in a list of frequencies and portion
sizes to calculate the usual daily intake of the four methyl-
group donors (mg or μg/day). Twenty-one FFQs were
obtained before pregnancy, 94 FFQs at 11–13 weeks, 85
FFQs at 18–22 weeks, 82 FFQs at 30–34 weeks of preg-
nancy, 79 FFQs 6–8 weeks PP, and 60 FFQs 6 months PP.
To assess the intake of methyl-group donors through
supplement use, questions were asked about the use of
nutritional supplements (frequency, brand/type, dosage)
before, during each trimester of pregnancy, and PP. Only
the intake of folic acid (synthetic form of folate) was regis-
tered, since there was no report on the supplemental
intake of methionine, betaine, and choline. Furthermore,
using a combination of questionnaires and interviews, we
collected information about a range of socio-demographic
factors, life style habits, and physical activity. Information
on mothers’ smoking status before and during pregnancy
was obtained at each consultation. Questions were asked
about smoking before and in each trimester of pregnancy
and the number of cigarettes smoked on average per day.
From these data, a dichotomous variable for maternal
smoking before and during pregnancy was derived (did
not smoke/smoked). Height and prepregnancy weight
were used to calculate the prepregnancy body mass index
(BMI, kg/m2).
Six months after birth, data on breastfeeding was derived
and scores were given ranging from 0–4 (0 = formula feed-
ing; 1 = <1 month of breastfeeding; 2 = 1–3 months
of breastfeeding; 3 = 3–6 months of breastfeeding;
4 = >6 months of breastfeeding). We measured
infant weight and length at the 6 months PP visit.
Maternal and neonatal measurements have been described
in more detail in a previous study [28].
Fig. 1 Flowchart of mother–infant pairs enrolled in the MANOE study and included in the statistical analysis
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Sample collection and DNA extraction
A Cytobrush plus Medscan® was used to brush against
the inner cheeks of the infant. The brush handle was cut
off and put inside a 15-mL Falcon tube with PBS and
stored immediately at −20 °C, until DNA extraction.
DNA extraction from cytobrush was performed using the
QIAamp DNA Blood Mini Kit (Qiagen Inc., Valencia,
CA). The final elution volume obtained was 100 μL.
The quantity and purity of DNA were determined by
a NanoDrop spectrophotometer.
Gene-specific DNA methylation measurements
Bisulfite conversion and PCR
Genomic DNA (200 ng) was bisulfite converted using
the EZ-96 DNA Methylation-Gold™ Kit (#D5008, Zymo
Research). Converted DNA was eluted with 30 μL of M-
elution buffer. Subsequently, 1 μL of converted DNA
was amplified by PCR in a total volume of 25 μL con-
taining 0.2 μM of primers and 2× Qiagen PyroMark
PCR Master Mix (#978703, Qiagen). Primers for DNMT1,
RXRA, and LEP were ordered from Qiagen (#PM00075761,
#PM00144431, #PM00129724 PyroMark CpG Assays). The
analyzed sequences are part of the promoter region and lie
within a CpG island. For the RXRA gene, the analyzed se-
quence also lies in a transcriptional regulatory site. Primer
sequences for IGF2 DMR were taken from the original
paper. Imprinting of the IGF2 gene is regulated by this dif-
ferentially methylated region which is located upstream of
the imprinted promoters of IGF2 exon 3 [31].
PCR for DNMT1, RXRA, and LEP consisted of an initial
hold at 95 °C for 15 min followed by 45 cycles of 30 s at
94 °C, 30 s at 54 °C, and 30 s at 72 °C. PCR amplification
ended with a final extension step at 72 °C for 10 min. PCR
for IGF2 DMR consisted of an initial hold at 5 °C for
15 min followed by 5 cycles of 30 s at 94 °C, 30 s at 68 °C,
and 30 s at 72 °C. This was followed by 50 cycles of 30 s at
94 °C, 30 s at 64 °C, and 30 s at 72 °C and ended with a
final extension step at 72 °C for 10 min.
Pyrosequencing
In order to assess CpG methylation levels, 20 μL of
biotinylated PCR product was immobilized to Streptavi-
din Sepharose High Performance beads (#17-5113-01,
GE Healthcare) followed by annealing to 25 μL of
0.3 μM sequencing primer at 80 °C for 2 min with a sub-
sequent 10 min cooling down period. Pyrosequencing
was performed using Pyro Gold reagents (#970802,
Qiagen) on the PyroMark Q24 instrument (Qiagen) fol-
lowing the manufacturer’s instructions. Pyrosequencing
results were analyzed using the PyroMark analysis 2.0.7
software (Qiagen). Five CpGs were analyzed for DNMT1,
three CpGs for IGF2 DMR, four CpGs for LEP, and five
CpGs for RXRA. Six samples were randomly selected for
technical variation analysis.
Statistical analysis
First, we assessed changes in the intake of maternal
methyl-group donors during and after pregnancy using a
multivariate regression model for longitudinal measure-
ments with methyl-group donor intake as a response
variable and time point as a factor (LSD post hoc test).
Next, we determined the effect of maternal methyl-
group donor intake on gene-specific DNA methylation
(IGF2 DMR, LEP, RXRA, DNMT1) using linear mixed
models. Linear mixed models were used with gene-
specific DNA methylation as a response variable and
methyl-group donor intake, CpG site, and their inter-
action as explanatory variables. Other covariates were
included in the multivariable model to correct for pos-
sible confounding. Potential confounders were selected
based on the association with infant DNA methylation
and maternal nutrition: maternal age, maternal prepreg-
nancy BMI, maternal smoking before and during each
trimester of pregnancy (0 = did not smoke before and
during pregnancy, 1 = smoked before and during preg-
nancy), gestational weight gain, and duration of breast-
feeding (0 = formula feeding; 1 = <1 month of
breastfeeding; 2 = 1–3 months of breastfeeding; 3 = 3–
6 months of breastfeeding; 4 = > 6 months of breastfeed-
ing). A random intercept was modeled to deal with the
clustered nature of the data. Analyses were performed
separately per time point (prepregnancy, 11–13 weeks
pregnancy, 18–22 weeks pregnancy, 30–34 weeks preg-
nancy). First, the interaction between maternal methyl-
group donor intake and CpG site was tested. A significant
interaction test implies that the association between
methyl-group donor intake and CpG methylation is differ-
ent between the individual CpGs. In this case, results were
reported per individual CpG. A non-significant interaction
test indicates lack of evidence for a differential association
between methyl-group donor intake and methylation at
different CpGs. In this case, a main effect of methyl-group
donor intake over the different CpGs was reported.
Next, an independent t test was performed on a sub-
sample of lactating women (n = 65) to assess the effect
of maternal choline intake during breastfeeding on
buccal DNA methylation at 6 months. The mean mater-
nal methyl-group donor intake during the 6 months
after delivery was calculated using the two FFQs admin-
istrated during this period and using supplement infor-
mation. Finally, we determined the effect of maternal
choline intake during lactation on gene-specific DNA
methylation (IGF2 DMR, LEP, RXRA, DNMT1) using
linear mixed models. Linear mixed models were used
with gene-specific DNA methylation as a response vari-
able and choline intake, CpG site, and their interaction
as explanatory variables. Other covariates were included
in the multivariable model to correct for possible
confounding. Potential confounders were selected based
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on the association with infant DNA methylation and
maternal nutrition: maternal age, maternal prepregnancy
BMI, maternal smoking, and gestational weight gain. A
random intercept was modeled to deal with the
clustered nature of the data. Analyses were performed
separately per time point (0–3 months postpartum, 3–
6 months postpartum). First, the interaction between
maternal choline intake and CpG site was tested. A
significant interaction test implies that the association
between choline intake and CpG methylation is different
between the individual CpGs. In this case, results were
reported per individual CpG. A non-significant inter-
action test indicates lack of evidence for a differential
association between choline intake and methylation at
different CpGs. In this case, a main effect of choline
intake over the different CpGs was reported.
All tests were two-sided, a 5% significance level was
assumed for all tests. Analyses have been performed
using SAS software (version 9.4 of the SAS System for
Windows).
Results
Characteristics of the 114 mother–infant pairs included
in the statistical analysis are presented in Table 1. The
mean maternal age and standard deviation (SD) was
31 ± 3.7 years, mean prepregnancy BMI and SD was
23 ± 3.4 kg/m2, and the mean gestational weight gain
and SD was 14.8 ± 4.1 kg. Only four women smoked
before and during the first trimester of pregnancy.
One woman continued smoking during the second
and third trimester. The infants, 54 of which were
girls (47.4%), had a mean weight and SD of 7875.4 ±
877.6 g, a mean length and SD of 67.9 ± 2.6 cm, and
the mean age and SD was 6.3 ± 2.4 months. Only 7%
of the women decided to exclusively use formula
feeding, while the biggest group of women (39.5%)
breastfed for more than 6 months.
Most of the women in the study had a methionine
intake above the daily requirement of 10.4 mg/kg body
weight per day [32]. Dietary methionine intake was
significantly lower 6 months PP (1533.6 mg/day) than
the intake in the third trimester (1659.3 mg/day, p = 0.043)
of pregnancy and 6–8 weeks PP (1678.5 mg/day, p = 0.01).
The dietary intake of folate, choline, and betaine was stable
and did not change during pregnancy and in the PP period
(Table 2). All women took a folic acid supplement in the
first trimester of pregnancy to reach an uptake of 400 μg of
folate per day. Remarkably, some continued taking the
supplement throughout pregnancy and lactation, despite
the recommendation of starting 4 weeks before conception
until 12 weeks of pregnancy [33].
The supplemental intake of folic acid on the other
hand was highest in the first trimester of pregnancy
(507.2 μg) and significantly different from the folic acid
intake in the other four time points (p = 0.000). Postpar-
tum, the intake of folic acid was significantly lower as
compared to the intake during every trimester of preg-
nancy. Within the PP period, the folic acid intake at
6 months (68 μg/day) was significantly lower than the
intake at 6–8 weeks (204.3 μg/day, p = 0.000). For
choline, the adequate choline intake was 425 mg for
non-pregnant women, 450 mg for pregnant women,
and 550 mg for lactating women [34]. Most women
had an average intake of about 300 mg choline per
day, which lies below the adequate intake. For beta-
ine, no guideline for dietary intake exists.
Gestational methyl-group donor intake and infant buccal
DNA methylation
We estimated the association of maternal methyl-group
donor intake before pregnancy and during each trimes-
ter of pregnancy on infant (6 months old) gene-specific
DNA methylation (DNMT1, IGF2 DMR, RXRA, and
LEP) in buccal epithelial cells. The statistically significant
associations and trends between maternal methyl-group
donor intake and buccal DNA methylation are presented
in Table 3.
Table 1 Maternal and infant characteristics (n = 114)
Characteristics Mean (SD) Range
Mother
Maternal age (years) 31 (3.7) 25–41
Prepregnancy BMI (kg/m2) 23 (3.4) 17.9–33
Gestational weight gain (kg) 14.8 (4.1) 5.3–28.9
Infant
Weight (g) 7875.4 (877.6) 6240–11,120
Length (cm) 67.9 (2.6) 62–76.5
Age (months) 6.3 (0.4) 4.6–7.2
% N
Maternal smoking (yes)
Before pregnancy 3.5 4
First trimester 3.5 4
Second trimester 0.9 1





0 months 7 8
<1 month 6.1 7
1–3 months 19.3 22
3–6 months 28.1 32
>6 months 39.5 45
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Before pregnancy, maternal betaine, folate, and folic
acid intakes were associated with buccal epithelial
methylation levels of RXRA, LEP, and IGF2 DMR. A
higher intake of folate and betaine was associated with
higher RXRA methylation across all CpGs (for folate,
0.685% increase in RXRA methylation per 100 μg folate
increase; 95% CI 0.245, 1.125; p = 0.027; for betaine,
0.875% increase in RXRA methylation per 100 mg
betaine increase; 95% CI 0.118, 1.633; p = 0.0241). In
addition, a higher intake of folate was associated with
lower LEP methylation across all CpGs (−1.233% de-
crease in LEP methylation per 100 μg folate increase;
95% CI −2.342, −0.125; p = 0.0298). For folic acid, a
higher intake before pregnancy was associated with
lower IGF2 DMR methylation across all CpGs (−0.706%
decrease in IGF2 DMR methylation per 100 μg folic acid
increase; 95% CI −1.242, −0.107; p = 0.0101).
In the first trimester of pregnancy, only borderline
significant results were found between maternal methyl-
group donor intake and IGF2 DMR and DNMT1
methylation.
In the second trimester of pregnancy, a higher intake
of folic acid was associated with lower DNMT1 methyla-
tion across all CpGs (−0.027% decrease in DNMT1
methylation per 100 μg folic acid increase; 95% CI
−0.051, −0.004; p = 0.0204).
In the third trimester of pregnancy, a higher intake of
choline and folate was associated with higher DNMT1
CpG1 methylation (0.156% increase in DNMT1 CpG1
methylation per 100 mg choline increase; 95% CI 0.029,
0.283; p = 0.0166) and higher DNMT1 CpG3 methylation
(0.131% increase in DNMT1 CpG3 methylation per
100 μg folate increase; 95% CI 0.016, 0.246; p = 0.0256),
respectively.
Choline intake of lactating women and infant methylation
First, we found statistically significant differences in buc-
cal RXRA methylation (CpG4 and mean CpG) between
low and high (≥275.27 mg/day) maternal dietary intake
of choline during lactation. The results are shown in
Fig. 2. We observed significantly higher RXRA methyla-
tion percentages when the mother consumed a diet high
in choline during lactation compared to a diet low in
choline (for CpG4, 5.7 ± 1.4 vs. 5 ± 1.2%, p = 0.023, 95%
CI −1.407, −1.083; for mean CpG, 7.3 ± 1.1 vs. 6.7 ±
1.2%, p = 0.04, 95% CI −1.180, −0.028).
Next, we estimated the association between choline
intake of lactating women during two time points (0–
3 months after pregnancy and 3–6 months after preg-
nancy) and infant gene-specific DNA methylation
(DNMT1, IGF2 DMR, RXRA, and LEP) in buccal epithe-
lial cells. No significant association between maternal
choline intake and infant DNA methylation levels was
found (Table 4).
Discussion
This research supports the hypothesis that maternal
methyl-group donor intake before and during pregnancy
could possibly induce epigenetic alterations in offspring
genes related to metabolism and genes important to main-
tain DNA methylation patterns. We first studied the effect
of maternal methyl-group donor intake (through diet and
supplements) before and during each trimester of preg-
nancy on gene-specific DNA methylation (IGF2 DMR,
Table 2 Intake of maternal methyl-group donors through diet and supplements (folic acid) during pregnancy and in the postpartum
(PP) period










































10.4 mg/kg body weight


















































p values were obtained using a multivariate regression model for longitudinal measurements
aMethionine intake 6 months PP was significantly lower than the intake in the third trimester of pregnancy and 6–8 weeks PP
bFolic acid intake was significantly higher in the first trimester of pregnancy compared to the other time points
cFolic acid intake in the PP period was significantly lower than the intake during pregnancy and within the PP period, folic acid intake 6 months PP was lower
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LEP, RXRA, DNMT1) in buccal epithelial cells of 6 months
old infants. We observed that maternal methyl-group
donor intake (folate, folic acid, betaine), only in the peri-
conception period, was associated with DNA methylation
in genes related to growth (IGF2 DMR), metabolism
(RXRA), and appetite control (LEP). For LEP, only a nega-
tive association was observed with prepregnancy folate in-
take. A similar negative association was found in studies
from the Dutch Hunger Winter where adult men exposed
to famine (low availability of methyl-group donors) in
utero had 2.8% higher LEP methylation levels than their
unexposed siblings [19]. In addition, we observed a nega-
tive association between IGF2 DMR methylation and folic
acid use before pregnancy and a borderline positive asso-
ciation in the first trimester of pregnancy. Haggarty et al.
[15] observed higher levels of IGF2 cord blood methyla-
tion when folic acid supplements were used after 12 weeks
of gestation as compared to use in the periconception
period. One other study reported no difference in IGF2
DMR cord blood methylation between infants born to no,
moderate, or high folic acid users before pregnancy [35].
On the other hand, Steegers-Theunissen et al. [36] re-
ported a 4.5% higher IGF2 DMR methylation in 17 months
old children when mother used a folic acid supplement of
400 μg per day in the periconceptional period. The differ-
ent reported conclusions in relation to the timing of folic
acid use could be important since changes in IGF2 methy-
lation could have unintended consequences for health and
disease. For RXRA, positive associations were observed
with prepregnancy betaine and folate intake. Other studies
have also reported both increases and decreases in methy-
lation depending on the timing of the exposure and locus
under study [19]. Ours and other results show that both
hypo- and hypermethylation can be found in offspring
exposed to a higher intake of methyl-group donors. There
is no simple correlation between maternal methyl-group
donor intake and offspring DNA methylation. It is rather
believed that these epigenetic modifications in the off-
spring are a coordinated adaptive response to environ-
mental challenges, whereby the developing offspring
adjusts their physiology to suit the expected postnatal
environment [3].
Table 3 Associations between maternal methyl-group donor intake (before and during pregnancy) and infant DNMT1, IGF2 DMR,
RXRA, and LEP methylation in buccal epithelial cells





















































































β-Estimate is an absolute change in percentage of methylation; slope >(<) 0 means positive (negative) association
aWhen there was no evidence for a differential association between maternal methyl-group donor intake and DNA methylation at the different CpG locations, the
main effect of maternal methyl-group donor intake over all CpG locations was reported
bWhen there was a significant interaction test, the association between maternal methyl-group donor intake and DNA methylation was different between CpG
locations. In this case, the results were reported per CpG location
CI confidence interval
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The periconception period, during which embryonic
development takes place, is a vulnerable period, where
nutritional exposures can disrupt the correct establish-
ment of epigenetic marks [1]. Studies from the Dutch
Hunger Winter show that adults who had been exposed
to famine early in gestation and late gestation had a 5.2
and 0.9% (not significant) lower methylation of the IGF2
DMR gene as opposed to unexposed same-sex siblings,
respectively (timing specific) [2, 5]. It is thought that
epigenetic marks set in the periconception period were
more stable and could be maintained for many cell
divisions (long-term stability), while marks set later in
gestation on the other hand seem to be more flexible and
can be removed within a few cell divisions (short-term
flexibility) [37]. It has been suggested that the stable epi-
genetic marks represent those determined by genetics,
whereas, the variable marks are more likely to be influ-
enced by the environment, for example, nutrition [38].
Our results also indicate that maternal methyl-group
donor intake during every trimester of pregnancy could
influence DNMT1 buccal DNA methylation in the in-
fant. In the first and second trimester of pregnancy,
lower intakes of maternal methyl-group donors resulted
in higher DNMT1 buccal DNA methylation levels. In
the third trimester on the other hand, higher maternal
methyl-group donor intake resulted in higher DNMT1
methylation. Several animal studies have reported altered
DNMT1 expression in offspring due to differences in
Fig. 2 Buccal RXRA methylation by maternal dietary choline intake during lactation. The graphs represent the mean methylation values and
standard error of the mean bars of 65 infants. The results are based on a low or high dietary maternal intake of choline during lactation. The
overall p values and significant p values with mean differences (MD) are also shown
Table 4 Associations between maternal choline intake during
lactation (0–3 months after pregnancy and 3–6 months after
pregnancy) and infant DNMT1, IGF2 DMR, RXRA, and LEP
methylation in buccal epithelial cells

































β-Estimate is an absolute change in percentage of methylation; slope >(<) 0
means positive (negative) association
aWhen there was no evidence for a differential association between maternal
choline intake and DNA methylation at the different CpG locations, the main
effect of maternal choline intake over all CpG locations was reported, which
was the case for all genes
CI confidence interval
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maternal diet (folic acid supplementation, low-protein
diet, low-choline diet) [39–42]. Kovacheva et al. [42]
reported that choline deficiency during gestation can
modulate the fetal DNA methylation machinery through
hypomethylation of the regulatory CpGs within the
DNMT1 gene, leading to its overexpression. It was already
shown that hypomethylation of a single CpG (position
101) in the DNMT1 gene can upregulate its expression
[43], which was confirmed in the previous study. Maternal
choline deficiency also resulted in an increased global and
gene-specific (IGF2) DNA methylation in fetal livers [42].
It has already been shown that DNMT1 is important for
the maintenance of IGF2 methylation patterns [44]. The
negative associations found between DNMT1 methylation
and maternal methyl-group donor intakes are in line with
the results from animal studies. This could also indicate
that the observed changes in DNA methylation in the
other genes could result from an increased expression of
DNMT1. However, in the third trimester of pregnancy, a
positive association was observed. This change in direc-
tion could be due to a shift in the I-C metabolism during
gestation. A higher rate of transsulfuration was previously
reported in the first trimester of pregnancy and a higher
rate of transmethylation in the third trimester [45].
It is becoming clear that nutrition cannot only affect
the epigenome in the prenatal life but that it extends
into the early postnatal period. Breast milk has the ideal
combination of nutrients, hormones, and other factors
essential for the proper development and health of
babies and seems to have a protective effect against the
development of obesity later in life [23]. Exclusive
breastfeeding is recommended by the World Health
Organization (WHO) for the first 6 months of life [46].
In this study, we found that 6 months old infants from
mothers who breast-fed for at least 3 months and had a
high dietary intake of choline (≥275.27 mg/day) had
statistically significant higher buccal RXRA CpG4 and
CpG mean methylation levels. However, we were not
able to reproduce these results when dividing the postna-
tal period in two periods (0–3 months and 3–6 months).
In the second analysis, we did not find an association
between maternal choline intake during lactation and
buccal DNA methylation. Results from other studies show
that the mean daily choline intake is about 300 mg/day
[47]. These results are in line with the mean daily choline
intake of women in the MANOE study (Table 2), but the
choline intake is still far below the adequate intake of
450 mg/day during pregnancy and 550 mg/day during lac-
tation. Maternal dietary choline intake can affect choline
breast milk composition and infant choline status. Folate
breast milk concentration on the other hand is maintained
even when the mother is folate deficient and is unaffected
by maternal folic acid supplementation [24]. In breast
milk, choline is mainly present as phosphocholine (45%)
and glycerophosphocholine (29%), with smaller amounts of
free choline (9%), phosphatidylcholine (7%), and sphingo-
myelin (10%). Ilcol et al. [48] have demonstrated that free
choline concentrations in breast milk were influenced by
maternal circulating choline status (serum free choline).
Also, serum-free choline concentrations in infants were
correlated with free choline, phosphocholine, glycero-
phosphocholine, and total choline contents of breast milk.
A possible explanation for the increase in RXRA
methylation in infants from breastfeeding mothers with
higher dietary choline intake during the first 6 months
could be through higher availability of methyl-group do-
nors in the I-C metabolism. Choline is first oxidized into
betaine, which contains three methyl-groups. A methyl-
group is donated to homocysteine for the formation of
methionine, which is further transformed to SAM. SAM
will eventually donate the methyl-group to the DNA and
is converted into S-adenosylhomocysteine (SAH). Thus,
a higher dietary intake of choline could lead to higher
DNA methylation levels through the provision of
methyl-group donors [49]. Next to the role of choline in
the I-C metabolism, it also plays a role in the lipid-
cholesterol transport and metabolism (choline is a pre-
cursor of phosphatidylcholine) [50]. A specific species of
phosphatidylcholine is the peroxisome proliferator-
activated receptor alpha (PPARα). PPAR and RXR form
heterodimers that regulate transcription of genes in-
volved in insulin action, adipocyte differentiation, lipid
metabolism, and inflammation [22]. According to a
study in two independent cohorts, greater cord blood
methylation of RXRA was strongly correlated with
greater adiposity in later childhood (9 years old). A 17,
20, and 6% increase in fat mass and a 10, 12, and 4
increase in percentage fat mass were found per SD
change in RXRA methylation [21]. A potential mechanis-
tic pathway involved is that the induction of transcrip-
tion by RXRA is dependent on its binding to ligands
including the peroxisome proliferator-activated recep-
tors. Our results indicate that a higher maternal choline
(≥275.27 mg/day) intake during lactation was linked with
higher RXRA methylation in infant’s buccal cells. We do
not know if the positive association found between
RXRA cord blood methylation and fat mass in 9-year-
old children [21] applies for RXRA buccal epithelial cell
methylation at 6 months of age and childhood fat mass.
In this study, we were not able to link our methylation
data with infant characteristics. Children of the MANOE
study will therefore be followed up at a later age, to link
the infant’s methylation levels with anthropometric
measurements (weight, height, and fat mass).
Many studies have found an association between small
DNA methylation changes at single CpGs or over a very
limited genomic region (<10% and often only 1–5%)
and disease phenotypes. Such small DNA methylation
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changes are known to be set during epigenetic sensitive
periods and play a role in creating a large diversity in
phenotypes linked to the onset of many complex diseases.
Our study also observed small changes in DNA
methylation, but the true biological relevance and
how these small changes could give rise to the disease
phenotype (mechanism) remains unknown [51].
There are some strengths and limitations in the present
study we need to address. The strengths of the present
study include a unique study design that allowed us to col-
lect longitudinal maternal data (starting before pregnancy,
during each trimester of pregnancy, and in the PP period)
and offspring gene-specific DNA methylation data in buc-
cal epithelial cells at the age of 6 months. The use of a val-
idated food-frequency questionnaire designed to assess
the intake of the nutrients under study adds to the
strength of our study. In addition, at each study time point
detailed information about supplement use was obtained.
We also have detailed covariate data allowing for
adjustment for potential confounding variables. Another
advantage is the use of bisulfite pyrosequencing for DNA
methylation analysis in candidate genes. It enables the
determination of DNA methylation levels at individual
CpG sites and the calculation of the average methylation
percentage of that region. Single CpG site methylation in
the promoter region of a gene can be involved in the regu-
lation of transcription, especially when it lies in a relevant
transcription factor binding site, and could be associated
with diseases. From example, the loss of DNA methylation
in one CpG site in the promoter region of TET1 was asso-
ciated with air pollution and childhood asthma and could
possibly be a potential biomarker for childhood asthma
[52]. CpG methylation within the same CpG island in pro-
moter regions has shown to be highly correlated and these
methylation patterns have been shown to differ from
methylation patterns elsewhere, indicating that they have
a specific biological role [53].
A first limitation is that we measured offspring methy-
lation in buccal epithelial cells and not in the target
tissue (adipose tissue). We do not know to what extent
the methylation changes found in buccal epithelial cells
reflect the changes in the less accessible target tissue
(adipose tissue). DNA extracted from buccal swabs
mainly stems from exfoliated epithelial cells but has a
more homogenous cell population compared to blood
samples. Buccal swabs are most often used in epidemio-
logical studies involving young children because it is
non-invasive and easy to obtain [27]. It has been shown
that buccal samples are more informative than blood
samples in DNA methylation studies with non-blood-
based diseases/phenotypes (for example obesity) as out-
come [54]. We have measured DNA methylation at the
age of 6 months and we do not know if these are the
methylation patterns set at birth or if it reflects
methylation changes due to early postnatal exposures.
Another limitation is the fact that the Belgian food com-
position database NUBEL [55] does not contain infor-
mation about the four methyl-group donors under
study. Databases of neighboring countries or the USDA
database for choline and betaine [56] content were used
in the validation of the FFQ [29, 30]. For folate, the Dutch
NEVO food composition database was used [57] and the
German BLS nutrient database for methionine [58]. The
USDA database was also used for the nutrient content of
folate and methionine if not found in NEVO and BSL
databases, respectively. In addition, in the validation of the
FFQ, we found a lower correlation coefficient (which mea-
sures the association between the FFQ and the reference
method) of 0.42 for choline [29]. The correlation coeffi-
cients should be at least 0.40 and optimally in the range of
0.50–0.70 [59]. A last limitation is that we have only
performed an analysis for technical variation in the pyro-
sequencing analysis and did not include control samples.
Conclusions
This study suggests that maternal dietary and supple-
mental intake of methyl-group donors, especially in early
gestation, can influence infant buccal DNA methylation in
genes related to metabolism, growth, appetite regulation,
and DNA methylation reactions. We have also shown that
nutrition in the early postnatal period, lactation, can
influence infant DNA methylation levels. Higher maternal
choline intake in mothers who breast-fed their children
for more than 3 months resulted in higher buccal RXRA
methylation levels in 6 months old infants.
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